vs

Side-by-side financial comparison of 8X8 INC (EGHT) and MYRIAD GENETICS INC (MYGN). Click either name above to swap in a different company.

MYRIAD GENETICS INC is the larger business by last-quarter revenue ($209.8M vs $185.1M, roughly 1.1× 8X8 INC). On growth, 8X8 INC posted the faster year-over-year revenue change (3.4% vs -0.4%). Over the past eight quarters, MYRIAD GENETICS INC's revenue compounded faster (1.9% CAGR vs 1.6%).

8x8, Inc. is an American provider of cloud communications and customer experience software for businesses. The company offers unified communications, contact center, and communications platform as a service (CPaaS) delivered via a cloud-based architecture. 8x8 is headquartered in Campbell, California. Its common stock trades on the Nasdaq under the ticker symbol EGHT, and the company is led by Samuel Wilson.

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

EGHT vs MYGN — Head-to-Head

Bigger by revenue
MYGN
MYGN
1.1× larger
MYGN
$209.8M
$185.1M
EGHT
Growing faster (revenue YoY)
EGHT
EGHT
+3.8% gap
EGHT
3.4%
-0.4%
MYGN
Faster 2-yr revenue CAGR
MYGN
MYGN
Annualised
MYGN
1.9%
1.6%
EGHT

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
EGHT
EGHT
MYGN
MYGN
Revenue
$185.1M
$209.8M
Net Profit
$5.1M
Gross Margin
63.9%
70.0%
Operating Margin
5.2%
-2.7%
Net Margin
2.8%
Revenue YoY
3.4%
-0.4%
Net Profit YoY
68.4%
EPS (diluted)
$0.04
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EGHT
EGHT
MYGN
MYGN
Q4 25
$185.1M
$209.8M
Q3 25
$184.1M
$205.7M
Q2 25
$181.4M
$213.1M
Q1 25
$177.0M
$195.9M
Q4 24
$178.9M
$210.6M
Q3 24
$181.0M
$213.3M
Q2 24
$178.1M
$211.5M
Q1 24
$179.4M
$202.2M
Net Profit
EGHT
EGHT
MYGN
MYGN
Q4 25
$5.1M
Q3 25
$767.0K
$-27.4M
Q2 25
$-4.3M
$-330.5M
Q1 25
$-5.4M
$-100.0K
Q4 24
$3.0M
Q3 24
$-14.5M
$-22.1M
Q2 24
$-10.3M
$-36.7M
Q1 24
$-23.6M
$-26.0M
Gross Margin
EGHT
EGHT
MYGN
MYGN
Q4 25
63.9%
70.0%
Q3 25
64.8%
69.9%
Q2 25
66.4%
71.2%
Q1 25
67.8%
68.5%
Q4 24
67.7%
71.7%
Q3 24
68.1%
70.2%
Q2 24
67.9%
69.6%
Q1 24
68.2%
68.1%
Operating Margin
EGHT
EGHT
MYGN
MYGN
Q4 25
5.2%
-2.7%
Q3 25
2.9%
-11.3%
Q2 25
0.3%
-154.5%
Q1 25
0.2%
-14.8%
Q4 24
5.0%
-18.6%
Q3 24
4.0%
-9.4%
Q2 24
-0.8%
-17.3%
Q1 24
-7.9%
-13.8%
Net Margin
EGHT
EGHT
MYGN
MYGN
Q4 25
2.8%
Q3 25
0.4%
-13.3%
Q2 25
-2.4%
-155.1%
Q1 25
-3.1%
-0.1%
Q4 24
1.7%
Q3 24
-8.0%
-10.4%
Q2 24
-5.8%
-17.4%
Q1 24
-13.1%
-12.9%
EPS (diluted)
EGHT
EGHT
MYGN
MYGN
Q4 25
$0.04
$-0.09
Q3 25
$0.01
$-0.29
Q2 25
$-0.03
$-3.57
Q1 25
$-0.04
$0.00
Q4 24
$0.02
$-0.47
Q3 24
$-0.11
$-0.24
Q2 24
$-0.08
$-0.41
Q1 24
$-0.20
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EGHT
EGHT
MYGN
MYGN
Cash + ST InvestmentsLiquidity on hand
$86.9M
$149.6M
Total DebtLower is stronger
$321.2M
$119.9M
Stockholders' EquityBook value
$142.9M
$368.0M
Total Assets
$661.5M
$706.6M
Debt / EquityLower = less leverage
2.25×
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EGHT
EGHT
MYGN
MYGN
Q4 25
$86.9M
$149.6M
Q3 25
$75.9M
$145.4M
Q2 25
$81.3M
$74.4M
Q1 25
$88.0M
$91.8M
Q4 24
$104.2M
$102.4M
Q3 24
$117.4M
$99.9M
Q2 24
$130.8M
$97.3M
Q1 24
$117.3M
$104.3M
Total Debt
EGHT
EGHT
MYGN
MYGN
Q4 25
$321.2M
$119.9M
Q3 25
$325.8M
$119.5M
Q2 25
$335.4M
Q1 25
$350.0M
Q4 24
$364.5M
Q3 24
$396.9M
Q2 24
Q1 24
$409.7M
Stockholders' Equity
EGHT
EGHT
MYGN
MYGN
Q4 25
$142.9M
$368.0M
Q3 25
$133.2M
$372.8M
Q2 25
$128.2M
$388.1M
Q1 25
$122.2M
$704.9M
Q4 24
$113.0M
$701.1M
Q3 24
$109.8M
$731.7M
Q2 24
$104.6M
$740.5M
Q1 24
$102.0M
$760.0M
Total Assets
EGHT
EGHT
MYGN
MYGN
Q4 25
$661.5M
$706.6M
Q3 25
$670.8M
$728.1M
Q2 25
$684.3M
$677.3M
Q1 25
$683.2M
$1.0B
Q4 24
$698.2M
$1.0B
Q3 24
$740.1M
$1.1B
Q2 24
$755.7M
$1.1B
Q1 24
$756.0M
$1.1B
Debt / Equity
EGHT
EGHT
MYGN
MYGN
Q4 25
2.25×
0.33×
Q3 25
2.45×
0.32×
Q2 25
2.62×
Q1 25
2.86×
Q4 24
3.23×
Q3 24
3.61×
Q2 24
Q1 24
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EGHT
EGHT
MYGN
MYGN
Operating Cash FlowLast quarter
$20.7M
$10.6M
Free Cash FlowOCF − Capex
$19.1M
FCF MarginFCF / Revenue
10.3%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
4.07×
TTM Free Cash FlowTrailing 4 quarters
$43.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EGHT
EGHT
MYGN
MYGN
Q4 25
$20.7M
$10.6M
Q3 25
$8.8M
$21.1M
Q2 25
$11.9M
$-13.6M
Q1 25
$5.9M
$-16.3M
Q4 24
$27.2M
$6.6M
Q3 24
$12.3M
$700.0K
Q2 24
$18.1M
$2.6M
Q1 24
$12.7M
$-18.6M
Free Cash Flow
EGHT
EGHT
MYGN
MYGN
Q4 25
$19.1M
Q3 25
$7.7M
Q2 25
$11.5M
Q1 25
$5.5M
Q4 24
$26.8M
Q3 24
$11.1M
Q2 24
$17.8M
Q1 24
$12.3M
FCF Margin
EGHT
EGHT
MYGN
MYGN
Q4 25
10.3%
Q3 25
4.2%
Q2 25
6.3%
Q1 25
3.1%
Q4 24
15.0%
Q3 24
6.1%
Q2 24
10.0%
Q1 24
6.9%
Capex Intensity
EGHT
EGHT
MYGN
MYGN
Q4 25
0.9%
Q3 25
0.6%
Q2 25
0.2%
Q1 25
0.2%
Q4 24
0.3%
Q3 24
0.7%
Q2 24
0.2%
Q1 24
0.2%
Cash Conversion
EGHT
EGHT
MYGN
MYGN
Q4 25
4.07×
Q3 25
11.52×
Q2 25
Q1 25
Q4 24
9.01×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EGHT
EGHT

Services$179.7M97%
Other$5.4M3%

MYGN
MYGN

Segment breakdown not available.

Related Comparisons